Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VALE vs GSK✓SelectedUSD · GSKVALE vs GSK performance historyLatest closeAs of-2.09%11/19
Stock and ETF performance explorer

VALE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-12.2%
GSK return
+5.3%
Excess return
-17.5%
Maximum drawdown
-43.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.1%-1.6%-0.5%-1.7%
7D-12.9%-4.7%-8.1%-11.9%
30D-24.5%-4.7%-19.8%-23.7%
3M-29.3%-8.8%-20.5%-27.5%
6M-36.8%-4.6%-32.2%-36.2%
YTD-22.4%+1.0%-23.4%-23.6%
1Y-12.2%+6.9%-19.0%-16.3%
All-12.2%+5.3%-17.5%-16.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling